Preprint
via OpenAlex
Active-site inhibition of the mammalian Target of Rapamycin
eScholarship (California Digital Library) · 2009
Deregulated nutrient-sensing
Altered intercellular communication
Rapamycin / mTOR inhibition
Human
Mouse
Abstract
Cell signaling pathways direct cell growth and differentiation during development and the improper growth and proliferation of cancer cells largely by directing the transcription of genes and the translation of these transcripts into proteins. Chapters 1 and 2 address the cellular properties of a new class of inhibitors of the mammalian Target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">Rapamycin(definition) (mTOR) kinase. mTOR sits at the hub of an important growth factor sensing pathway and its activity controls the translation of proteins important for cell growth and proliferation. Rapamycin is a small molecule natural product and an allosteric inhibitor of mTOR which is commonly used as an immunosupressant and is being investigated for the treatment of cancer. Rapamycin has even been shown to extend lifespan in mice. New inhibitors that target the active site of mTOR have very different cellular effects than rapamycin and may prove useful in the treatment of human diseases and cancer. Chapter 3 examines the effects of isoform specific PI3-K inhibitors on insulin signaling. Discovering specific inhibitors of protein and lipid kinases requires testing many inhibitors against many kinases. When we assay kinases \\invitro, we use a nitrocellulose membrane to capture the phosphorylated substrate. Chapter 4 describes an image analysis program specifically designed to analyze membrane capture kinase assays. Chapter 5 investigates the adaptability of the highly conserved interface between a homeodomain transcription factor and its target gene. Homeodomain transcription factors are highly conserved regulators of metazoan body development that control development by binding to DNA and regulating the transcription of their target gens. Adaptability of homeodomain transcription factor binding is examined in Chapter 5 though the biochemical, biophysical and structural characterization of an adapted mutant of the engrailed homeodomain.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Feldman, M.E. (2009). Active-site inhibition of the mammalian Target of Rapamycin. <em>eScholarship (California Digital Library)</em>. https://openalex.org/W2285480073
Vancouver
Feldman ME. Active-site inhibition of the mammalian Target of Rapamycin. eScholarship (California Digital Library). 2009.
BibTeX
@unpublished{morris2009Active,
title = {Active-site inhibition of the mammalian Target of Rapamycin},
author = {Morris E. Feldman},
journal = {eScholarship (California Digital Library)},
year = {2009},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Hematology & Oncology 2019
Open access · CC-BY
Targeting mTOR for cancer therapy
Research and Reports in Biology 2015
Open access · CC-BY
Recent insights into the pathophysiology of mTOR pathway dysregulation
Signal Transduction and Targeted Therapy 2023
Open access · CC-BY
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease
Frontiers in Oncology 2019
Open access · CC-BY
mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer
IUBMB Life 2013
Open access · OA
Role of energy‐ and nutrient‐sensing kinases AMP‐activated Protein Kinase (AMPK) and Mammalian Target of Rapamycin (mTOR) in Adipocyte Differentiation
International Journal of Molecular Sciences 2018
Open access · CC-BY